Table: GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes.
Med Lett Drugs Ther · 2024
Last updated 2026-05-28| Journal | Med Lett Drugs Ther, 2024 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 39137181 ↗